A new point-of-care instrument for detection of respiratory pathogens, including Streptococcus pneumonia and Bordetella pertussis.
Health care providers working in small and medium-sized hospitals tend to lack easy access to centralised lab services. The cost of diagnostics accounts for up to 10% of the total hospital costs per patient. A fast diagnosis, followed by adequate patient treatment, not only reduces lab testing costs, but also improves control and surveillance of target pathogens.
RESPOC will permit health professionals to better control respiratory infection pathogens that cause illnesses such as pneumonia and whooping cough.These infections can result in serious problems, especially in children.
By having access to the new diagnostics device RESPOC, hospitals will reduce misdiagnoses and the subsequent spread of antimicrobial resistance resulting from an excessive prescription of antibiotics.
For patients, RESPOC will result in the satisfaction of an earlier diagnosis of respiratory infection pathogens, a non-invasive sample collection and a shortened hospital stay.
Expected commercial launching: 2016
Funding: FP7-SME-2013-1- 606488